AMYLOIDOSIS

Clinical trials for AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 19 Not yet recruiting 1 Not yet finished but already full! 3 Completed 5 Terminated 1

Experimental drug cocktail aims to tame rare protein disease

Disease control Not yet recruiting

This study is testing a new four-drug combination for adults recently diagnosed with AL amyloidosis, a rare disease where abnormal proteins damage organs. It is for people who are not candidates for a stem cell transplant. Researchers want to see if adding a new drug called belan…

Matched conditions: AMYLOIDOSIS

Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

AMYLOIDOSIS

Get alerted when new AMYLOIDOSIS trials appear

Experimental drug cocktail aims to tame rare protein disease